NutriBand (NTRB) Change in Receivables (2018 - 2026)
NutriBand's (NTRB) quarterly Change in Receivables came in at -$29158.0 in Q1 2026, up 18.51% year-on-year from -$24602.9 in Q1 2025, and down 120.19% quarter-over-quarter from -$13242.0 in Q4 2025.
NutriBand (NTRB) Change in Receivables (2018 - 2026) Analysis & Trends
NutriBand has disclosed Change in Receivables across 9 years of filings, most recently posting -$29158.0 for Q1 2026.
- Change in Receivables for Q1 2026 came in at -$29158.0, up 18.51% year-over-year; the trailing twelve-month figure through Jan 2026 was $44557.0 (up 159.57% YoY), and the FY2026 annual result was $44557.0, up 159.57% from the prior year.
- Change in Receivables came in at -$29158.0 for Q1 2026 at NutriBand, down from -$13242.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $85508.0 in Q1 2024 to a low of -$66102.0 in Q4 2022.
- The 5-year median for Change in Receivables is $20289.0 (2025), against an average of $7548.5.
- Across the five-year window, Change in Receivables slumped 298.34% in 2022 and jumped 489.12% in 2025, its largest moves.
- NutriBand's Change in Receivables stood at -$66102.0 in 2022, then gained by 18.64% to -$53783.0 in 2023, then jumped by 177.38% to $41619.0 in 2024, then slumped by 131.82% to -$13242.0 in 2025, then slumped by 120.19% to -$29158.0 in 2026.
- The last three Change in Receivables figures came in at -$29158.0 (Q1 2026), -$13242.0 (Q4 2025), and $66668.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -29,158.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -29,158.00 |
| Jan 31, 2026 | -29,158.00 |
| Oct 31, 2025 | -13,242.00 |
| Oct 31, 2025 | -13,242.00 |
| Jul 31, 2025 | 66,668.00 |
| Jul 31, 2025 | 66,668.00 |
| Apr 30, 2025 | 20,289.00 |
| Apr 30, 2025 | 20,289.00 |
| Jan 31, 2025 | -35,783.00 |
| Jan 31, 2025 | -35,783.00 |
| Oct 31, 2024 | 41,619.00 |
| Oct 31, 2024 | 41,619.00 |
| Jul 31, 2024 | -17,133.00 |
| Jul 31, 2024 | -17,133.00 |
| Apr 30, 2024 | -63,505.00 |
| Apr 30, 2024 | -63,505.00 |
| Jan 31, 2024 | 85,508.00 |
| Jan 31, 2024 | 85,508.00 |
| Oct 31, 2023 | -53,783.00 |
| Oct 31, 2023 | -53,783.00 |